Dec. 9, 2021
The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) and the Western States Scientific Safety Review Committee today authorized for emergency use the Pfizer-BioNTech COVID-19 vaccine for 16- and 17-year-olds, at least six months after they received their second shot of that vaccine.
A breakthrough case is when a vaccinated person gets infected with the virus they were vaccinated against. When more people get vaccinated, there are more people in the pool who can get a breakthrough infection. As vaccination rates rise, breakthrough infections may also rise. In the case of COVID-19, this doesn’t mean the vaccines aren’t working.
For example, for the week of Nov. 28 through Dec. 4, there were approximately 3 1/2 times as many cases among unvaccinated people as there were among those who are fully vaccinated. People who do get a breakthrough infection are also much less likely to experience severe disease than unvaccinated people.
 
On Dec. 8, 2021, the Food and Drug Administration (FDA) authorized AstraZeneca’s Evusheld under emergency use for prevention of COVID-19 in certain adults and children. Evusheld is a long-acting monoclonal antibody therapy.
Evusheld is not a vaccine, but it can block the virus’ attachment and entry into human cells. It is intended for people who are at high risk of severe disease and may not mount a strong immune response from the COVID-19 vaccine and for those who cannot be vaccinated. Read more here.
OHA’s most recent update on COVID-19 breakthrough cases, released today, found that 69.4% of the 6,496 reported COVID-19 cases between Nov. 28 and Dec. 4 occurred in unvaccinated people.
There were 1,989 breakthrough cases, accounting for 30.6% of all cases.
The average age of the breakthrough cases during that period was 43. Forty-four breakthrough cases involved residents of care facilities, senior living communities or other congregate care settings. There were 64 breakthrough cases in people aged 12 to 17.
To date, there have been 47,687 COVID-19 vaccine breakthrough cases in Oregon. The average age of all cases is 47. Breakthrough cases have been reported in all 36 counties.
Cases of COVID-19 are far more common in unvaccinated people. The report shows that the rate of COVID-19 in unvaccinated people is more than 3-1/2 times higher than in vaccinated people.
To date, 4.4% of all vaccine breakthrough cases have been hospitalized and 1.2% have died. The average age of vaccinated people who died was 81.
Vaccination remains the most effective tool to reduce the spread of COVID-19. To date more than 2.9 million Oregonians have received at least one dose of a COVID-19 vaccine.
The latest breakthrough report can be found here.
We want to keep you informed about COVID-19 in Oregon. Data are provisional and change frequently.
• Samples for 542,901 tests have been reported positive.
• Samples for 7,711,787 tests have been reported negative.
COVID-19 hospitalizations
The number of hospitalized patients with COVID-19 across Oregon is 404, which is seven more than yesterday. There are 94 COVID-19 patients in intensive care unit (ICU) beds, which is six fewer than yesterday.
There are 56 available adult ICU beds out of 682 total (8% availability) and 247 available adult non-ICU beds out of 4,171 (6% availability).
The total number of patients in hospital beds may fluctuate between report times. The numbers do not reflect admissions per day, nor the length of hospital stay. Staffing limitations are not captured in this data and may further limit bed capacity.
Note: Please do not visit an emergency department for COVID-19 testing, unless you require emergency care for your symptoms.
Emergency departments in Oregon are under significant strain. You can find a test here. If you have a medical condition that doesn’t require emergency care, contact your provider. An urgent care center may also help you get the care you need and will save emergency departments from added strain.
More information about hospital capacity can be found here.
Today, OHA reported that 32,291 new doses of COVID-19 vaccinations were added to the state immunization registry Dec. 8. Of that total, 2,136 were initial doses, 2,716 were second doses and 10,986 were third doses and booster doses. The remaining 16,351 were administered on previous days but were entered into the vaccine registry Dec. 8.
The seven-day running average is now 23,668 doses per day.
Oregon has now administered 3,600,843 doses of Pfizer Comirnaty, 111,760 doses of Pfizer pediatric, 2,341,352 doses of Moderna and 247,962 doses of Johnson & Johnson COVID-19 vaccines.
As of today, 2,981,287 people have had at least one dose of a COVID-19 vaccine and 2,706,196 people have completed a COVID-19 vaccine series.
These data are preliminary and subject to change.
Updated vaccination data are provided on Oregon’s COVID-19 data dashboards and have been updated today.
There are 38 new COVID-19 related deaths in Oregon, raising the state’s death toll to 5,356, Oregon Health Authority (OHA) reported at 12:01 a.m. today.
OHA reported 901 new confirmed and presumptive cases of COVID-19 as of 12:01 a.m. today bringing the state total to 399,361
The new confirmed and presumptive COVID-19 cases reported today are in the following counties: Baker (2), Benton (16), Clackamas (94), Clatsop (8), Columbia (11), Coos (34), Crook (13), Deschutes (55), Douglas (43), Grant (2), Harney (4), Hood River (9), Jackson (57), Jefferson (8), Josephine (13), Klamath (13), Lane (61), Lincoln (9), Linn (69), Malheur (4), Marion (88), Morrow (2), Multnomah (127), Polk (23), Tillamook (8), Umatilla (6), Wallowa (1), Wasco (7), Washington (92), and Yamhill (22).
To learn more about the COVID-19 vaccine situation in Oregon, visit our webpage (English or Spanish), which has a breakdown of distribution and other information.
Did someone forward this to you? You can subscribe here.
|
|
